Kimelman & Baird LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 160,179 shares of the company’s stock, valued at approximately $20,583,000.
Other large investors also recently bought and sold shares of the company. Frazier Financial Advisors LLC purchased a new stake in Merck KGaA in the second quarter worth about $25,000. Rakuten Securities Inc. purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $27,000. Delos Wealth Advisors LLC purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $33,000. Solstein Capital LLC bought a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $39,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Up 3.8%
Shares of OTCMKTS:MKGAF opened at $164.12 on Friday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a fifty day simple moving average of $163.35 and a two-hundred day simple moving average of $149.06. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The stock has a market capitalization of $21.21 billion, a price-to-earnings ratio of 25.06 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
